BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9655280)

  • 1. Can scintimammography reduce "unnecessary" biopsies?
    Flanagan DA; Gladding SB; Lovell FR
    Am Surg; 1998 Jul; 64(7):670-2; discussion 673. PubMed ID: 9655280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prone scintimammography in patients with suspicion of carcinoma of the breast.
    Khalkhali I; Mena I; Jouanne E; Diggles L; Venegas R; Block J; Alle K; Klein S
    J Am Coll Surg; 1994 May; 178(5):491-7. PubMed ID: 8167887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging.
    Palmedo H; Grünwald F; Bender H; Schomburg A; Mallmann P; Krebs D; Biersack HJ
    Eur J Nucl Med; 1996 Aug; 23(8):940-6. PubMed ID: 8753683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of axillary lymph node metastasis of breast carcinoma with technetium-99m sestamibi scintimammography.
    Tolmos J; Khalkhali I; Vargas H; Stuntz M; Cutrone J; Mishkin F; Diggles L; Venegas R; Klein S
    Am Surg; 1997 Oct; 63(10):850-3. PubMed ID: 9322655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
    Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
    J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive predictive value of 99mTc sestamibi scintimammography in patients with non-palpable, mammographically detected, suspicious, breast lesions.
    Lumachi F; Zucchetta P; Marzola MC; Ferretti G; Povolato M; Paris MK; Brandes AA; Bui F
    Nucl Med Commun; 2002 Nov; 23(11):1073-8. PubMed ID: 12411835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-phase 99mTc-sestamibi scintimammography and trans-scan in diagnosing breast cancer.
    Melloul M; Paz A; Ohana G; Laver O; Michalevich D; Koren R; Wolloch Y; Gal R
    J Nucl Med; 1999 Mar; 40(3):376-80. PubMed ID: 10086698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of the usefulness of combined mammography and scintimammography in suspected primary breast cancer using ROC curves.
    Buscombe JR; Cwikla JB; Holloway B; Hilson AJ
    J Nucl Med; 2001 Jan; 42(1):3-8. PubMed ID: 11197976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of early and double phase 99Tcm-sestamibi scintimammography in the diagnosis of breast cancer.
    Paz A; Melloul M; Cytron S; Koren R; Ohana G; Michalevich D; Gal R; Wolloch Y
    Nucl Med Commun; 2000 Apr; 21(4):341-8. PubMed ID: 10845222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between 99mTc-sestamibi scintimammography and X-ray mammography in the characterization of clusters of microcalcifications: a prospective long-term study.
    Grosso M; Chiacchio S; Bianchi F; Traino C; Marini C; Cilotti A; Manca G; Volterrani D; Roncella M; Rampin L; Marzola MC; Rubello D; Mariani G
    Anticancer Res; 2009 Oct; 29(10):4251-7. PubMed ID: 19846982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of scintimammography as an additional test to conventional mammography in detection of breast cancer].
    Cwikła JB; Buscombe JR; Kolasińska AD; Holloway B; Hilson AJ
    Ginekol Pol; 2003 May; 74(5):362-70. PubMed ID: 12931463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical utility of Tc-99m sestamibi scintimammography in detecting multicentric breast cancer.
    Vargas HI; Agbunag RV; Kalinowski A; Tolmos J; Klein SR; Diggles L; Khalkhali I
    Am Surg; 2001 Dec; 67(12):1204-8. PubMed ID: 11768831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
    Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
    Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scintimammography with Tc-99m sestamibi.
    Khalkhali I; Iraniha S; Cutrone JA; Diggles LE; Klein SR
    Acta Med Austriaca; 1997; 24(2):46-9. PubMed ID: 9227786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (99)mTc-3PRGD2 scintimammography in palpable and nonpalpable breast lesions.
    Liu L; Song Y; Gao S; Ji T; Zhang H; Ji B; Chen B; Jia B; Wang F; Xu Z; Ma Q
    Mol Imaging; 2014; 13(5):. PubMed ID: 24825112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
    Prats E; Aisa F; Abós MD; Villavieja L; García-López F; Asenjo MJ; Razola P; Banzo J
    J Nucl Med; 1999 Feb; 40(2):296-301. PubMed ID: 10025838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scintimammographic analysis of nonpalpable breast lesions previously identified by conventional mammography.
    Tolmos J; Cutrone JA; Wang B; Vargas HI; Stuntz M; Mishkin FS; Diggles LE; Venegas RJ; Klein SR; Khalkhali I
    J Natl Cancer Inst; 1998 Jun; 90(11):846-9. PubMed ID: 9625173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Scintimammography with 99mTC-MIBI in the clinical practice: repercussion on the clinical management of the patient].
    Prats E; Razola P; Sainz JM; Tardín L; Andrés A; Abós MD; García F; Fernández J; Villavieja L; Banzo J
    Rev Esp Med Nucl; 2007; 26(3):153-9. PubMed ID: 17524309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of Tc-99m-MIBI for breast carcinoma in correlation with mammography and sonography.
    Habib S; Maseeh-uz-Zaman ; Hameed A; Niaz K; Hashmi H; Kamal S
    J Coll Physicians Surg Pak; 2009 Oct; 19(10):622-6. PubMed ID: 19811712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tc-99m tetrofosmin scintigraphy as an adjunct to plain-film mammography in palpable breast lesions.
    Fenlon HM; Phelan N; Tierney S; Gorey T; Ennis JT
    Clin Radiol; 1998 Jan; 53(1):17-24. PubMed ID: 9464430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.